Since the M6 subtype of AML is derived from erythrocytes, we further investigated the expression of CLL-1 on erythrocytes (CD235a+), but no expression was detected, indicating that CLL-1 might not be a target for AML-M6 (Fig. 1f). The gene discussed is GYPA; the disease is acute myeloid leukemia.